WuXi Biologics (02269.HK) issued a total of 1.502 million shares under the pre-purchase rights plan for the initial public offering.

Zh tng cijng APP xn, yo mng shngw (02269.HK) fb gnggo, gnj gngs y 2016 nin 1 yu 5 r cin de shuc gngki f shu qin gu gqun jhu (y 2016 nin 8 yu 10 r xidng) wi xngsh qqun r fxng ptng g htng 150.2 wn g. Intelligence Finance APP News, WuXi Biologics (02269.HK) announced that, based on the company's first public offering of pre-emptive purchase rights plan (revised on August 10, 2016) adopted on January 5, 2016, a total of 1.502 million shares of common stock were issued for exercising the options.